David A. Siegel Prime Medicine, Inc. Transaction History

Two Sigma Advisers, LP

  • $43.8 Billion
  • Q2 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 176,500 shares of PRME stock, worth $610,690. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176,500
Previous 164,000 7.62%
Holding current value
$610,690
Previous $1.15 Million 20.99%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.3 - $8.03 $53,750 - $100,374
12,500 Added 7.62%
176,500 $907,000
Q1 2024

May 15, 2024
BUY
$6.35 - $9.39 $749,300 - $1.11 Million
118,000 Added 256.52%
164,000 $1.15 Million
Q4 2023

Feb 14, 2024
BUY
$5.59 - $9.55 $257,140 - $439,300
46,000 New
46,000 $407,000

Others Institutions Holding PRME

# of Institutions
126
Shares Held
64.7M
Call Options Held
127K
Put Options Held
51.3K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $331M
More about PRME
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email